GLP-1 receptor agonists such as semaglutide and tirzepatide are FDA-regulated for chronic weight management in adults with a BMI of 30 or higher, or 27 with a weight-related condition. Las Vegas runs around the clock, and dealers, servers, performers and resort staff working overnight and rotating shifts rarely fit a daytime clinic into their week - even as the job keeps appearance and stamina front of mind. Telehealth works on their clock: a licensed Nevada physician reviews your online assessment under Nevada Revised Statutes §629.515, and compounded medication from an FDA-registered 503B pharmacy ships to your Las Vegas address. Monthly cost runs $199–$379 versus about $1,247 for brand-name Ozempic or Wegovy. Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Serving Las Vegas ZIP codes: 89101, 89102, 89104, 89109, 89119.
Local clinics serving Tule Springs: Premier Physicians Weight Loss & Wellness, Kohn Medical & Weight Loss: Ronald Kohn, MD and Luana Lifestyle Weight Loss Clinic. Many patients compare these in-person options against licensed GLP-1 telehealth — prescribed online, shipped to the door.
For Tule Springs residents, the essentials on tirzepatide. Tirzepatide is the newest and most potent molecule in the incretin class: it is the first approved dual GIP/GLP-1 agonist, often chosen when semaglutide plateaus.
Eligibility is not fixed: a patient who is not eligible today may become so if their medical situation changes. Eligibility rests mostly on BMI and comorbidities: a higher threshold on its own, or a lower one when an associated condition like prediabetes or hypertension is present.
Around Tule Springs in Clark County, 3 weight-management practice(s) are listed locally. On the cost side, expect about $250-600/month compounded via telehealth; about $1,000-1,400/month brand-name without insurance. Typical dosing: 2.5 - 5 - 7.5 - 10 - 12.5 - 15 mg/week, stepped up by tolerance and goal. The area's median income (~$66,356) weighs on the brand-vs-compounded trade-off in Tule Springs.
Yes: both are tirzepatide. Mounjaro is dosed/labeled for type 2 diabetes, Zepbound for weight management.
Often a BMI of 30 or higher, or 27 or higher with a weight-related comorbidity, but only the medical evaluation decides.
In the SURMOUNT head-to-head trials, tirzepatide produced greater average weight loss, likely thanks to its dual GIP + GLP-1 action. Response is individual and should be assessed by a physician.
Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Licensed in Nevada. All prescriptions issued under Nevada Revised Statutes §629.515 and supervised by Nevada State Board of Medical Examiners.